Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 16
1946 62
1947 63
1948 64
1949 70
1950 75
1951 78
1952 73
1953 75
1954 67
1955 77
1956 79
1957 72
1958 70
1959 65
1960 75
1961 62
1962 59
1963 56
1964 62
1965 59
1966 76
1967 56
1968 62
1969 195
1970 230
1971 239
1972 208
1973 381
1974 318
1975 241
1976 334
1977 411
1978 296
1979 292
1980 280
1981 250
1982 319
1983 424
1984 381
1985 467
1986 418
1987 465
1988 514
1989 441
1990 550
1991 547
1992 597
1993 609
1994 602
1995 640
1996 552
1997 613
1998 624
1999 672
2000 854
2001 594
2002 658
2003 598
2004 686
2005 712
2006 590
2007 612
2008 581
2009 574
2010 619
2011 776
2012 751
2013 832
2014 906
2015 828
2016 721
2017 708
2018 626
2019 586
2020 761
2021 738
2022 653
2023 576
2024 371

Text availability

Article attribute

Article type

Publication date

Search Results

30,266 results

Results by year

Filters applied: . Clear all
Page 1
Reply to Finsterer.
Kanberg N, Schöll M, Edén A, Gisslén M. Kanberg N, et al. J Infect Dis. 2024 Mar 14;229(3):920-921. doi: 10.1093/infdis/jiad549. J Infect Dis. 2024. PMID: 38036488 No abstract available.
Long COVID After Bamlanivimab Treatment.
Evering TH, Moser CB, Jilg N, Yeh E, Sanusi B, Wohl DA, Daar ES, Li JZ, Klekotka P, Javan AC, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. J Infect Dis. 2023 Aug 31;228(Suppl 2):S126-S135. doi: 10.1093/infdis/jiad286. J Infect Dis. 2023. PMID: 37650236 Clinical Trial.
Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk.
Paraskevis D, Gkova M, Mellou K, Gerolymatos G, Psalida N, Gkolfinopoulou K, Kostaki EG, Loukides S, Kotanidou A, Skoutelis A, Thiraios E, Saroglou G, Zografopoulos D, Filippou D, Mossialos E, Zaoutis T, Gaga M, Tsiodras S, Antoniadou A. Paraskevis D, et al. J Infect Dis. 2023 Dec 20;228(12):1667-1674. doi: 10.1093/infdis/jiad324. J Infect Dis. 2023. PMID: 37565522 Free PMC article.
The Multiple Origins of Ebola Disease Outbreaks.
Judson SD, Munster VJ. Judson SD, et al. J Infect Dis. 2023 Nov 13;228(Suppl 7):S465-S473. doi: 10.1093/infdis/jiad352. J Infect Dis. 2023. PMID: 37592878 Free PMC article. Review.
Reply to McShane.
Hill PC, Cobelens F, Martinez L, Garcia-Basteiro AL, Behr MA, Rangaka MX, Churchyard G, Evans T, Hanekom W, White RG. Hill PC, et al. J Infect Dis. 2024 Feb 14;229(2):616. doi: 10.1093/infdis/jiad466. J Infect Dis. 2024. PMID: 37897697 No abstract available.
A Single-Dose Intranasal Combination Panebolavirus Vaccine.
Malherbe DC, Kimble JB, Atyeo C, Fischinger S, Meyer M, Cody SG, Hyde M, Alter G, Bukreyev A. Malherbe DC, et al. J Infect Dis. 2023 Nov 13;228(Suppl 7):S648-S659. doi: 10.1093/infdis/jiad266. J Infect Dis. 2023. PMID: 37469133
30,266 results
You have reached the last available page of results. Please see the User Guide for more information.